Jim Middelburg

Preconditioning of the tumor microenvironment with oncolytic reovirus converts CD3-bispecific antibody treatment into effective immunotherapy

S. H. van der Burg, D. Mustafa, T. van Hall, 2020, Journal for ImmunoTherapy of Cancer.

Overcoming Challenges for CD3-Bispecific Antibody Therapy in Solid Tumors

A. Labrijn, K. Kemper, T. van Hall, 2021, Cancers.

PLGA nanoparticles loaded with beta‐lactoglobulin‐derived peptides modulate mucosal immunity and may facilitate cow's milk allergy prevention

J. Garssen, C. van Nostrum, W. Hennink, 2018, European journal of pharmacology.

Imaging the pharmacokinetics and therapeutic availability of the bispecific CD3xTRP1 antibody in syngeneic mouse tumor models

S. Heskamp, J. Molkenboer-Kuenen, T. van Hall, 2023, bioRxiv.